Could the committee come to order?
I would like to welcome everybody and ask everyone to please be seated. We're going to have quite a rigorous morning today.
Pursuant to Standing Order 108(2), I'd like to welcome you to the third meeting of post-market surveillance of pharmaceutical products, prescription and non-prescription.
We have with us witnesses who will be taking part in today's panel on federal, provincial, and territorial issues. I'd like to welcome the witnesses who made it today.
Unfortunately, one of our witnesses, Ms. Susan Paetkau, from the Ontario Ministry of Health, will not be with us today due to the bad weather in Toronto. If any of us has ever gone through Toronto on a snowy day, we know we often have the same problem she's had.
We do have witnesses. There are representatives from the Canadian Institute for Health Information and the Patent Medicine Prices Review Board.
I would like to remind witnesses that they have ten minutes per organization to make their presentations. The committee will hear all presentations before proceeding to questions from the members of the committee.
I would like to begin with Ms. Glenda Yeates, president and CEO of the Canadian Institute for Health Information. Welcome to the committee, Ms. Yeates.